FDA NDC Directory · JSON-LD · Markdown

Cevimeline

NDC 63304-479 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerSun Pharmaceutical Industries, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA020989
Dosage form / routeCAPSULE · ORAL
Active ingredientsCEVIMELINE HYDROCHLORIDE (30 mg/1)
Marketing started20160310
Marketing ended20270430
Package count1

External sources

Source: openFDA. Public-domain (CC0).